Appointments and Second Opinions

Speak with one of our New Patient Coordinators to schedule an appointment, refer a patient or request a second opinion. In urgent cases, we can typically see new patients within 24 hours.

Contact us
Find Clinical Trials

We sponsor and collaborate on clinical trials that break new ground in pediatric cancer and blood disorder treatment. 

Search Pediatric Cancer and Blood Disorder Clinical Trials
Our Affiliations
HMS Affiliate

Dana-Farber/Boston Children's is a teaching affiliate of Harvard Medical School.

Our Affiliations

Steven DuBois, MD, MS

  • Director, Experimental Therapeutics
  • Senior Physician
  • Associate Professor of Pediatrics, Harvard Medical School

Office Phone

  • 617-632-5460

Appointment Phone

  • 888-733-4662 (new)
  • 617-632-3270 (established)

Fax

  • 617-632-5710

General

Treatment Centers

Discipline

Clinical Interests

Ewing sarcoma, Neuroblastoma, Novel agents, Other pediatric solid tumors, Phase 1 clinical trials

Location

Background

Board Certifications

  • Pediatric Hematology/Oncology, 2009

Fellowship

  • Boston Children's Hospital/Dana-Farber Cancer Institute, Pediatric Hematology/Oncology, 2007

Residency

  • University of California, San Francisco School of Medicine, Pediatrics, 2003

Internships

  • University of California, San Francisco School of Medicine, Pediatrics, 2001

Medical School

  • University of California, San Francisco School of Medicine, 2000

Biography

Dr. DuBois is director of experimental therapeutics at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center. He is a pediatric oncologist with an active clinical and translational research program focused on patients with advanced neuroblastoma and Ewing sarcoma. He conducts phase 1 and 2 clinical trials of novel targeted agents. His clinical practice focuses on providing outstanding team-based care for children and young adults with solid cancers. He is also a member of the American Pediatric Society.

Research

Dr. DuBois is director of experimental therapeutics at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center. He is a pediatric oncologist with an active clinical and translational research program focused on patients with advanced neuroblastoma and Ewing sarcoma. He conducts phase 1 and 2 clinical trials of novel targeted agents.

Physician Video